Earnings Feed
Start Free
Orexigen Therapeutics, Inc.·4

Nov 18, 6:47 PM ET

DUNAYEVICH EDUARDO 4

4 · Orexigen Therapeutics, Inc. · Filed Nov 18, 2009

Insider Transaction Report

Form 4
Period: 2009-11-16
Orexigen Therapeutics, Inc.OREX
DUNAYEVICH EDUARDO
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2009-11-16$2.00/sh+75,000$150,000→ 75,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2009-11-16−75,000→ 156,741 total
    Exercise: $2.00Exp: 2016-09-27→ Common Stock (75,000 underlying)
  • Sale

    Common Stock

    2009-11-16$7.50/sh−75,000$562,500→ 0 total
Footnotes (3)
  • [F1]This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/09/2009.
  • [F2]25% of the original grant vested on 8/8/2007. The remaining shares vest 1/36 per month until 8/8/2010.
  • [F3]Not applicable to this transaction.

Documents

2 files